Estrophilin detection

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

23230B, 424 15, 424 12, G01N 3348, G01T 100, A61K 4300, G01N 2306

Patent

active

042935369

ABSTRACT:
Estrogen receptor protein, estrophilin, in a tissue sample is detected and quantified by radiochemical methods involving selective binding of the protein to controlled pore glass beads. Also disclosed are methods for selectively removing undesirable degradation products from radiochemically labelled non-polar steroid reagents, especially estradiol.

REFERENCES:
Truong et al., Chem. Abstracts, vol. 83, No. 11, Sep. 15, 1975, Astract #93229h.
Fishman et al., J. Clin. Endocrinol, Metab., 39: 603-606 (1974).
Korenman et al., J. Clin. Endocrinol. Metab., 30: 639-645 (1970).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Estrophilin detection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Estrophilin detection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrophilin detection will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1206466

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.